- E75.21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E75.21 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E75.21 – other international versions of ICD-10 E75.21 may differ.
ICD-10-CM E75.21 is grouped within Diagnostic Related Group(s):
- 642 Inborn and other disorders of metabolism
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E75.21:
- corporis diffusum > Angiokeratoma
- Fabry-Anderson disease > in G31.2
- Sweeley-Klionsky > Disease, diseased
- Fabry\’s disease > glomerular (in) N05.9
- Fabry disease (-Anderson) > in (due to) E85.4
- glycolipid > Lipidosis E75.6